OBJECTIVES: We evaluated the postoperative @entity2103 after @entity5513 ( @entity5513 ) surgery and analyzed factors causing it. MATERIAL AND METHODS: We included 89 consecutive @entity1 undergoing surgical excision of unilateral @entity5513 . @entity1 and @entity5 characteristics, surgical approaches, @entity2103 , extent of @entity5 resection and complications were analyzed. RESULTS: Complete @entity5 resection was achieved in 85% of cases. Anatomic preservation of the facial nerve was achieved in 96% of @entity1 . In all @entity5 stages, 88.2% of @entity1 , have a normal or subnormal facial function within one year of the intervention, the rate was 100% in @entity1 carrying a @entity5513 stage I or II. No severe complication or @entity204 was reported. CONCLUSION: Short- and long-term facial nerve outcome was comparable with results of other recent series reported in literature. The @entity2103 after surgery was better with small @entity5513 compared to large @entity5513 . The intraoperative decision of near-total excision of the @entity5 followed by adjuvant radiotherapy, in some cases, can prove to be a good option in the interest of better preservation of the @entity2103 . The adhesion of the facial nerve and its complex relationship with the @entity5 remain mysterious; RMI can bring significant refinements, helping to get the best preservation offacial function rate, in the coming years.

[Facial nerve outcome after @entity5513 surgery: About 89 XXXX ].

@entity1 :: ('9606', 'Species') :: ['patients', 'Patient'] @entity5513 :: ('MESH:D009464', 'Disease') :: ['VS', 'vestibular schwannoma'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor'] @entity2103 :: ('MESH:D005155', 'Disease') :: ['facial nerve function'] @entity204 :: ('MESH:D003643', 'Disease') :: ['death']
@entity1 :: (9606,Species) :: ['patients']
